Ascletis Pharma Inc.

About Us
Corporate Overview Management Team Board of Directors Contact Us
Our Focus
Metabolic Diseases Viral Diseases Cancer Exploratory Indications
Products&Pipeline
Pipeline Products Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis
2017-08-18

© 2018 Ascletis Pharma Inc.

All Rights Reserved

contact

pr@ascletis.com
bd@ascletis.com

hr@ascletis.com
clinicaltrials@ascletis.com

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1